Ethnic differences in 25-hydroxyvitamin D levels and response to treatment in CKD

International Urology and Nephrology

Volumn 45, Issue 1, 2013, Pages 181-189

  Sanchez, Iris ^a   Mangoo Karim, Roberto ^a   Stubbs, Jason R ^c   Yanev, George P ^a   Wetmore, James B ^b  

^a South Texas Kidney Specialists PA   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS PAN AMERICAN   (United States)

Author keywords

25 hydroxyvitamin D; Chronic kidney disease; Ethnicity; Mineral metabolism; Race; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CREATININE; ERGOCALCIFEROL; PARATHYROID HORMONE;

AGED; ARTICLE; CAUCASIAN; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; GLOMERULUS FILTRATION RATE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PROTEINURIA; RETROSPECTIVE STUDY; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADULT; AGED; AGED, 80 AND OVER; CALCIUM; CREATININE; DIABETES MELLITUS; DIETARY SUPPLEMENTS; ERGOCALCIFEROLS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; TEXAS; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS; YOUNG ADULT;

EID: 84873414013     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0200-6     Document Type: Article

References (42)

1. Gonzalez EA, Sachdeva A, Oliver DA, Martin KJ (2004) Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 24:503-510
2. Zehnder D, Landray MJ, Wheeler DC et al (2007) Crosssectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study. Nephron Clin Pract 107:c109-116
3. Al-Badr W, Martin KJ (2008) Vitamin D and kidney disease. Clin J Am Soc Nephrol 3:1555-1560
4. Mehrotra R, Kermah D, Budoff M, Salusky IB, Mao SS, Gao YL, Takasu J, Adler S, Norris K (2008) Hypovitaminosis D in chronic kidney disease. Clin J AmSoc Nephrol 3:1144-1151
5. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31-38
6. Ishimura E, Nishizawa Y, InabaMet al (1999) Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 55:1019-1027
7. Melamed ML, Astor B, Michos ED, Hostetter TH, Powe NR, Muntner P (2009) 25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol 20:2631-2639
8. LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, Graves KL, Moe SM (2005) Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 45:1026-1033
9. Helvig CF, Cuerrier D, Hosfield CM et al. Dysregulation of renal vitamin D metabolism in the uremic rat. Kidney Int 78:463-472
10. de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS (2007) 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 50:69-77
11. Patel SR, Ke HQ, Vanholder R, Koenig RJ, Hsu CH (1995) Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins. J Clin Invest 96:50-59
12. Smogorzewski MJ, Massry SG (2003) Liver metabolism in CRF. Am J Kidney Dis 41:S127-132
13. Dusso AS, Brown AJ, Slatopolsky E (2005) Vitamin D. Am J Physiol Renal Physiol 289:F8-28
14. Ritter CS, Armbrecht HJ, Slatopolsky E, Brown AJ (2006) 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int 70:654-659
15. Dusso AS, Sato T, Arcidiacono MV, Alvarez-Hernandez D, Yang J, Gonzalez-Suarez I, Tominaga Y, Slatopolsky E (2006) Pathogenic mechanisms for parathyroid hyperplasia. Kidney Int Suppl S8-11
16. Ford ES, Ajani UA, McGuire LC, Liu S (2005) Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 28:1228-1230
17. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM (2005) Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 28:2926-2932
18. Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Korfer R, Stehle P (2003) Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure J Am Coll Cardiol 41:105-112
19. Martins D, Wolf M, Pan D et al (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167:1159-1165
20. Zittermann A (2003) Vitamin D in preventive medicine: are we ignoring the evidence Br J Nutr 89:552-572
21. Cantorna MT, Zhu Y, Froicu M, Wittke A (2004) Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 80:1717S-1720S
22. Cantorna MT, Mahon BD (2004) Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 229:1136-1142
23. Peterlik M, Cross HS (2005) Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest 35:290-304
24. Peterlik M, Cross HS (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1-201
25. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461-470
26. Al-Aly Z, Qazi RA, Gonzalez EA, Zeringue A, Martin KJ (2007) Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis 50:59-68
27. Zisman AL, Hristova M, Ho LT, Sprague SM (2007) Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol 27:36-43
28. DeVille J, Thorp ML, Tobin L, Gray E, Johnson ES, Smith DH(2006) Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease. Nephrology (Carlton) 11:555-559
29. Kandula P, Dobre M, Schold JD, Schreiber MJ Jr., Mehrotra R, Navaneethan SD (2011) Vitamin D supplementation in chronic kidney disease: a systematic review and metaanalysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 6:50-62
30. Armas LA, Hollis BW, Heaney RP (2004) Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89:5387-5391
31. Chandra P, Binongo JN, Ziegler TR, Schlanger LE, Wang W, Someren JT, Tangpricha V (2008) Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract 14:10-17
32. Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R (1998) Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 68:854-858
33. Ginde AA, Liu MC, Camargo CA Jr. (2009) Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 169:626-632
34. Hagenau T, Vest R, Gissel TN, Poulsen CS, Erlandsen M, Mosekilde L, Vestergaard P (2009) Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int 20:133-140
35. Benjamin A, Moriakova A, Akhter N, Rao D, Xie H, Kukreja S, Barengolts E (2009) Determinants of 25-hydroxyvitamin D levels in African-American and Caucasian male veterans. Osteoporos Int 20:1795-1803
36. Harris SS, Soteriades E, Coolidge JA, Mudgal S, Dawson-Hughes B (2000) Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. J Clin Endocrinol Metab 85:4125-4130
37. Jacob AI, Sallman A, Santiz Z, Hollis BW (1984) Defective photoproduction of cholecalciferol in normal and uremic humans. J Nutr 114:1313-1319
38. Cuppari L, Carvalho AB, Draibe SA (2008) Vitamin D status of chronic kidney disease patients living in a sunny country. J Ren Nutr 18:408-414
39. Stavroulopoulos A, Porter CJ, Roe SD, Hosking DJ, Cassidy MJ (2008) Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4. Nephrology (Carlton) 13:63-67
40. Holden RM, Morton AR, Garland JS, Pavlov A, Day AG, Booth SL Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol 5:590-597
41. Schmidt-Gayk H, Grawunder C, Tschope W, SchmittW,Ritz E, Pietsch V, Andrassay K, Bouillon R (1977) 25-hydroxyvitamin-D in nephrotic syndrome. Lancet 2:105-108
42. Grymonprez A, Proesmans W, Van Dyck M, Jans I, Goos G, Bouillon R (1995) Vitamin D metabolites in childhood nephrotic syndrome. Pediatr Nephrol 9:278-281